News
Oct 3, 2024
HOPO Therapeutics awarded BARDA contract of up to $226 million
Nov 2, 2023
HOPO Therapeutics jointly awarded $1.78M ARPA-E Grant
Jun 9, 2023
Phase 1 Clinical Trial of HOPO 14-1 Now Recruiting
Jun 8, 2023
CEO Julian Rees named 2023 Activate Fellow
May 15, 2023
Launch of Phase 1 Clinical Trial for HOPO 14-1
Dec 16, 2022
Poets & Quants names HOPO Therapeutics a 2022 Most Disruptive MBA Startup
Nov 25, 2022
HOPO Therapeutics named as an awardee in CLS Inspire QuickFire Challenge for BIPOC Communities
Oct 25, 2022
Berkeley Haas Features HOPO & VP Hannah Weber
Jun 22, 2022
HOPO Therapeutics completes California Life Sciences FAST Program
May 19, 2022
Plutonium targets immune response, lipid homeostasis, other cellular processes
Mar 5, 2022
Hannah Weber joins HOPO Therapeutics as VP, Strategy & Business Development
Jan 5, 2022
Toxicity mechanisms of gadolinium uncovered
Nov 23, 2021
New strategic direction for the company announced
Nov 4, 2021
HOPO Therapeutics joins Pad-13 program at Berkeley SkyDeck
Jul 5, 2021
HOPO Therapeutics team awarded 2021 Bakar Fellowship from UC Berkeley
Jul 1, 2021
Rebecca Abergel granted tenure
Jun 14, 2021
Letter to stakeholders from CEO Julian Rees
Jun 7, 2021
Lanthanide toxicity research highlighted by NPR's Marketplace, Berkeley Lab
Apr 28, 2021
New research details toxicity mechanisms of the lanthanides
Feb 3, 2021
HOPO-Einsteinium complex published in Nature
Jun 2, 2020
HOPO's chelator featured in Cancer Cytopathology
Mar 1, 2020
Prior Press Coverage of HOPO's Foundational Work
Feb 27, 2020
HOPO Therapeutics, Inc. is established
Publications
Proceedings of the National Academy of Sciences • Apr 2021
Genome-wide toxicogenomic study of the lanthanides sheds light on the selective toxicity mechanisms associated with critical materials
Roger M. Pallares, David Faulkner, Dahlia D. An, Solene Hebert, Alex Loguinov, Michael Proctor, Jonathan A. Villalobos, Kathleen A. Bjornstad, Chris J. Rosen, Christopher Vulpe, Rebecca J. Abergel
Nature • Feb 2021
Structural and spectroscopic characterization of an einsteinium complex
Korey P. Carter, Katherine M. Shield, Kurt F. Smith, Zachary R. Jones, Jennifer N. Wacker, Leticia Arnedo-Sanchez, Tracy M. Mattox, Liane M. Moreau, Karah E. Knope, Stosh A. Kozimor, Corwin H. Booth, Rebecca J. Abergel
Scientific Reports • Mar 2018
Evaluating the potential of chelation therapy to prevent and treat gadolinium deposition from MRI contrast agents
Julian A. Rees, Gauthier J.-P. Deblonde, Dahlia D. An, Camille Ansoborlo, Stacey S. Gauny, Rebecca J. Abergel
New Journal of Chemistry • Feb 2018
Toxic heavy metal – Pb, Cd, Sn – complexation by the octadentate hydroxypyridinonate ligand archetype 3,4,3-LI(1,2-HOPO)
Gauthier J.P. Deblonde, Trevor D. Lohrey, Dahlia D. An, Rebecca J. Abergel